ArticleHereditary cancer in clinical practice2016
Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality.
D G Evans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it